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Objective: To compare the usage of antibiotics and the resistance frequencies in blood culture isolates in a low- 
consumption area (Roskilde County, Denmark) in the period 1992-1995. 
Methods: Data from relevant institutions were collected and processed. 
Results: In 1995 the total use of antibiotics was 16.7 defined daily doses (DDD) 1000 inhabitants per day, 95% of this 
being in  the primary healthcare sector. In primary health care, only 0.1% of the total use was cephalosporins, 2% 
fluoroquinolones, 11% tetracyclines, 29% macrolides and 59% penicillins. In hospitals, 7% were cephalosporins, 3% 
fluoroquinolones, 0.7% tetracyclines, 10% macrolides and 59% penicillins. The total use in hospitals was 37 DDD/100 
bed-days. Resistance frequencies did not change in  the period. Resistance against penicillin and erythromycin in 
Sfreptococcus pneumoniae was 0.6% and 1.8% respectively. Resistance against methicillin in  Staphylococcus aureus 
was 0.8%, and resistance against ampicillin, cefuroxime, gentamicin and fluoroquinolones in Escherichia coli was 31%, 
0.5%, 0.8% and 0.8%. respectively. The frequencies of multiresistant coagulase-negative staphylococci correlated with 
the use of antibiotics in different ward groups according to  the use of antibiotics. 
Conclusions: In this 4-year study period, the changes in the use of antibiotics were negligible and were not reflected 
as alterations in  the resistance frequencies in single species. In an area with a low use of antibiotics, like Roskilde County, 
the frequency of multiresistant coagulase-negative staphylococci may reflect the use of antibiotics in  different wards. 
For comparison, it is of great importance to  report resistance frequencies and the consumption of antibiotics in different 
regions in  a uniform manner, preferably by DDD/1000 inhabitants per day in  the primary healthcare sector and as 
DDD/100 bed-days in hospitals. 
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INTRODUCTION 
The correlation between the use of antibiotics and the 
development of resistance in bacteria is well docu- 
mented [l-131, and the need for surveillance programs 
has often been emphasized [14-191. 
The consumption of antibiotics in Scandinavia is 
probably among the lowest per capita in the world. 
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Compared to other Scandinavian countries, Denmark 
has the lowest consumption of antibiotics as measured 
by defined daily doses (DDD)/1000 inhabitants per 
year [20] .  Few studies are, however, available concern- 
ing antibiotic consumption on a smaller scale, i.e. 
communities or counties. 
We therefore thought it of interest to report the 
antibiotic consumption in a Danish county, covering 
both the primary and secondary healthcare sectors over 
a 4-year period and compare these data with the 
resistance frequencies in blood culture isolates. 
MATERIALS AND METHODS 
Roskilde County 
Roskilde County is situated in the central parts of the 
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island of Zealand, approximately 50 km west of the 
capital Copenhagen. The county covers an area of 
892 km2, 1148th of Denmark. From 1992 to 1995 the 
number of inhabitants averaged 222 072 (220 129- 
224 052), 1/24th of the total population in Denmark 
[21]. In the study period, the primary health care was 
provided by an average of 136 (131-138) general 
practitioners. There are two regional semi-specialized 
hospitals with approximately 615 beds. One hospital is 
situated in the city of Roskilde and one in Koge. Both 
nephrology (hemodialysis) and, to a certain degree, 
hematologic patients are treated in the medical wards, 
but the wards are not specialized to the level of a 
university hospital. There are two intensive care units, 
one at each hospital. The total number of inpatient 
bed-days used in the county averaged 210 635 per year 
(206 263-215 492 bed-daydyear). In this study the 
number of inpatient bed-days is used as the denomin- 
ator for comparison. In 1992 the Statens Serum Institut 
(center for prevention and control of infectious diseases 
and congenital disorders in Denmark) upgraded the 
microbiological service in Roskilde County, thereby 
receiving all bacteriologic samples from both the 
primary and the secondary healthcare sector for further 
investigation. Besides what was done in the laboratory, 
the two hospitals received clinical microbiological 
guidance at a personal level. Twice a week at the 
intensive care unit in Roskilde and once a week at all 
other relevant wards in the county, a senior micro- 
biologist participated in one of the daily conferences. 
If needed, the consultant attended other wards on 
request. At all other times a microbiologist was on call 
and could be reached by telephone for both clinical 
advice and diagnostic laboratory work. 
The senior microbiologist is a member of the 
County Pharmacologic Advising Committee as well as 
the Infection Control Committee. 
Bacteriology 
As part of the routine, data sheets were made for 
all of the positive blood cultures (Colorbact, SSI, 
Copenhagen, Denmark). These sheets contain demo- 
graphic information about the episode. From these data 
sheets the bacterial species and their resistance patterns 
were extracted in the period from January 1992 to 
January 1996. All isolates were registered, i.e. there was 
no distinction between ‘true’ pathogens and contamin- 
ants. Only one isolate per 14 days was registered, in 
order to rule out identical isolates from the same 
patient. If more than one species was isolated, all 
were included in the study. In this material no 
distinction was made between community-acquired 
and hospital-acquired infections. For each isolate the 
ward of origin was registered, in order to relate the 
resistance patterns to the use of antibiotics. The three 
most common species were registered separately 
(Escherichia coli, Streptococcus pneumoniae and Staphylococcus 
aureus), and the remainder in relevznt groups. Routine 
susceptibility testing was performed by tablet diffusion 
(Rosco, Roskilde, Denmark) on Danish Blood Agar 
(SSI, Copenhagen, Denmark) using breakpoints as 
shown in Table 5. In order to achieve a larger number 
of isolates from the different wards, isolates of the same 
species or group of species from evcry year in the study 
period were summed. 
Antibiotic usage 
Until the beginning of 1992 all offi(:ial data concerning 
the use of antibiotics in Denmark originated &om the 
pharmaceutical industry. The data did not include the 
increasing amount of parallel imported antibiotics. 
Due to the increasing proportion of parallel imported 
antibiotics, reports from the industry became more and 
more unreliable concerning the exact amount used. 
Furthermore, it was not possible to distinguish between 
the use in hospitals and that in primary health care. In 
a country like Denmark, where the authorities try to 
modulate the use of antibiotics by changing the 
subsidies for different kinds of antibiotics, the need for 
surveillance of the use of antibiotics was obvious. Thus, 
the Danish Ministry of Health decreed that all 
pharmacies from January 1994 should report all their 
sales to The Danish Medicines Agency using data 
originating from the prescription. 
Danish inhabitants all have a personal identification 
number (CPR number) [22]. This number is used at all 
contacts with the social security system and it is 
therefore written on all prescriptions, as well as the 
unique registration number of the doctor prescribing. 
Along with these data, the pharm.icy also reports the 
package code for the drug sold and this is automatically 
converted to DDDs by computer. A. DDD is a technical 
unit recommended by the World Hlealth Organization. 
It represents an estimated daily average maintenance 
dose for an adult receiving the medicine on its main 
indication. As all antibiotics in Denmark are sold only 
by prescription, these conditions now make it possible 
to determine which doctor has prescribed what, how 
much and to whom. In the first thxe years of the study 
period no reliable data of governmental or industrial 
origin were available. All data concerning the use of 
antibiotics in primary health care and in hospitals 
originate &om the Roskilde County administration and 
from the pharmacy at the main hospital respectively. 
Concerning the Anatomical Therapeutic Chemical 
Classification System codes (ATC: codes), data were 
originally drawn from the datatiase at level 5 (to 
the generic name) for all antibiotics in group JOl. 
4 2 4  C l i n i c a l  M i c r o b i o l o g y  a n d  I n f e c t i o n ,  Vo lume 4 Number  8, A u g u s t  1998  
Furthermore, groups A07AA09 (vancomycin used 
orally as an intestinal anti-infective agent), GOlAFOl 
(metronidazole used as a gynecologic anti-infective 
agent) and POlAI301 (metronidazole used as an agent 
against amoebiasis and other protozoan diseases) were 
included because they contribute to a major part of the 
use of vancomycin and metronidazole, despite the fact 
that they account for a very small proportion of the 
total use. A minor amount of anti-infectives is not 
included in this investigation, namely systemic anti- 
niycotics 002) and systemic chemotherapeutics (J03), 
accounting for only a total of 31 DDDs in this 4-year 
period, and tuberculostatics 004). Later, data from 
hospitals were reclassified according to 10 therapeutic 
groups: extended-spectrum penicillins, penicillins G 
and V, penicillinase-stable penicillins, cephalosporins, 
sulfomethizole and trimethoprim, macrolides, amino- 
glycosides, fluoroquinolones, metronidazole and 
‘others’. For comparison with the use in primary health 
care, data were placed in 10 slightly different groups. 
The use of tetracycline and fusidic acid was specified 
from the group ‘Other’, and all the penicillins were 
placed in a common group. 
The use of all antibiotics delivered to the different 
wards in the hospitals was registered as DDDs at the 
dispensary at the main hospital via the unique package 
code. All antibiotics returned to the pharmacy as 
outdated or delivered as a result of clerical error were 
subtracted in the year of delivery. The use of antibiotics 
in different wards was calculated according to medical 
speciality. It was not possible to differentiate between 
the use in different subspecialities, i.e. nephrology or 
oncology, unless they had their own separate medical 
management and own account at the pharmacy. 
If a patient received his medication in the intensive 
care unit, the use of antibiotics was registered there. 
Data for usage in hospitals are presented as DDD/100 
bed-days. Data concerning the use of bed-days origin- 
ate from the hospital administrations, as reported to the 
National Board of Health. 
In order to increase the sample size of blood culture 
isolates when making comparisons with resistance 
frequencies, the different wards were grouped into 
three major groups according to the average use of 
antibiotics: the low-usage group, ward group 3, used 
less than 26 DDD/100 bed-days, the medium-usage 
group, ward group 2, used between 25 and 100 
DDD/l00 bed-days, and ward group 1 used more than 
100 DDD/100 bed-days. Although the pediatric ward 
had a consumption of 22 DDD/100 bed-days, it was 
included in ward group 2 in order to get a more realistic 
expression of the selection pressure. Assuming that an 
average child weighs one third to half the weight of an 
adult, the number of patients treated in pediatric wards 
will be at  least twice as high, since the DDD has been 
defined in adults. 
The primary healthcare data included all anti- 
biotics with the above mentioned ATC codes sold to 
inhabitants in Roslulde County or delivered to general 
practitioners in the county. Data were presented as 
DDD/1000 inhabitants per day. Data concerning 
the number of inhabitants originated from Statistics 
Denmark. 
Statistics 
Fisher’s exact or chi-square tests were used to compare 
frequencies. Correlation was tested by Spearman‘s 
rank correlation test. A p value <0.05 was considered 
to be significant. 
RESULTS 
Use of antibiotics 
In Table 1 the amount of antibiotics used in Koskilde 
County in 1995 is shown, totalling 1 366 273 DDDs, 
corresponding to 16.7 DDD/1000 inhabitants per day. 
Of this, 5.5% was used in hospitals and 94.5% in 
primary health care. In both settings, the use of 
penicillins accounted for 59% of the total use. In 
primary health care, the use of macrolides and tetra- 
cycline amounted to 20% and 12%) respectively, and in 
hospitals to 11% and 0.7%) respectively. In primary 
health care, fluoroquinolones amounted to 2% and 
cephalosporins to 0.1%, and in hospitals to 3% and 7%, 
respectively. 
Primary health care 
From 1992 to 1994 there was an increase in the use 
of antibiotics in primary health care from 14.0 
DDD/1000 inhabitants per day to 16.2 DDD/1000 
inhabitants per day. From 1994 to 1995 there was a 
2.5% decrease to 15.8 DDD/1000 inhabitants per 
Table 1 Use of antibiotics in Roskilde County 1995 
Primary health care Hospitals 
Total me  of  antibiotics (DDD) 1 290 655 
Tetracycline (‘HI) 
Chloraniphemcol (9%) 
Penicillins (“A) 
Cephalosporins (“A) 
Sulfonamides/Trimeth 
Macrolides (“A) 
Aminoglycosides (“A) 
Fluoroquinolones (%) 
Metronidazole (“A) 
Other (‘X) 
12 
59 
0.0 
0.1 
iopriiii (5%) 6 
20 
0.0 
2 
1 
0 
75 618 
0 7 
0 0 
59 
7 
0.7 
11  
6 
3 
7 
5.6 
Total (%I) 100 100 
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Table 2 
groups 
Use of antibiotics in different wards as DDD/100 bed-days, arranged according to the three ward 
Total antibiotic use recorded as Pe rentage of 
Number DDD/100 bed-days milltiresistant 
of beds CNS' 
1995 1992 1993 1994 1995 Average 1992-95 
Ward group 1 32 
ICUS 14 227 249 263 232 243 
Medical wards 210 42 49 45 41 44 
Orthopedc surgery 78 53 48 46 43 48 
Parenchymal surgery 110 52 50 43 39 46 
Ophthalmology 2 65 13 46 27 38 
Otorhinology 13 78 57 46 41 55 
Pediatricsa 37 23 31 20 15 22 
Rheumatology 16 25 17 16 19 
Geriatrics 32 21 18 20 21 20 
Neurology 32 14 20 17 11 15 
Gynecology/obstetrics 70 25 29 25 21 25 
Total for hospitals 614 43 46 41 37 42 
Ward group 2 12 
Ward group 3 7 
'Pediatric ward placed in ward group 2 according to the selection pressure; further explanation in the text 
1992 included In the medical ward. 'Further explanation in the text. 
day. These changes cover greater fluctuations in the stable penicillins, there were decreases in the use of 
different therapeutic subgroups that could be relevant extended-spectrum penicillins and combination of 
for the selection pressure. Although there were minor amoxycillin and clavulanic acid of. 7% (p<O.OOl)  and 
increases in the use of penicillins G and V and 22% (p<O.OOl)  respectively. The use of fluoro- 
cephalosporins, 2.6% @<0.001) and 3.2% ( p < O . O O l )  quinolones was almost doubled, but was limited to 0.30 
respectively, and an unchanged use of penicillinase- DDD/1000 inhabitants per day (data not shown). 
DDD/100 bed-day 
50 
45 
40 
35 
30 
25 
20 
15 
10 
5 
0 
Quinolones 
Other 
Metronidazole 
Aminoglycosides 
Macrolides 
Sulfomethizole and Trhethoprim 
Cephalosporins 
Penicillinme-resistvlt pnicillins 
Extended-spectrum penicillins 
Penicillins GandV 
1 
1992 1993 1994 1995 
Figure 1 Use of different groups of antibiotics in hospitals in Roskilde County in the study period. 
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Table 3 Use of antibiotics in relation to hospital activity 
1992 1993 1994 1995 
Demographics 
Outpatient bed-days& 
Inpatient bed-days 
Total bed-days 
Outpatient bed-days in % of total 
Discharges 
(including death, outpatients and inpatients) 
Antibiotic use 
DDD/100 bed-days' 
DDD/discharge 
DDDItotal bed-days 
10 921 
207 625 
218 546 
5.3 
36 753 
43 
41 
2.5 
11 890 
213 158 
225 048 
5.6 
37 961 
46 
43 
2.6 
13 037 
215 492 
228 529 
6.0 
39 441 
41 
39 
2.2 
18 618 
206 263 
224 881 
9.0 
37 619 
37 
34 
2.0 
'The patient doe? not stay at the hospital overnight bAs reported to the National Board of Health 
Hospitals 
In Figure 1 the use of antibiotics in hospitals is shown 
for the different years. As can be seen, the total amount 
increased from 43 DDD/100 bed-days in 1992 to 46 
DDD/100 bed-days in 1993. After this year, there was 
an annual decrease, from 1993 to 1994 an 11% decrease, 
and from 1994 to 1995 a further 10% decrease. The 
fraction of all penicillins declined from 63% to 59% 
(p<0.001) of the total, maslung an increase from 7% 
to 13% @<0.001) in the use of penicillinase-stable 
penicillins. In the same period the fraction of cephalo- 
sporins used was reduced from 9.9% to 7.2% @<0.001) 
of the total, corresponding to a 39.5% reduction (from 
4.3 DDD/100 bed-days to 2.6 DDD/100 bed-days). 
There were no other major changes in the use of the 
different groups of antibiotics in the hospitals. 
Table 2 shows the use of antibiotics in different 
wards. As can be seen, there were great differences in 
the amount of antibiotics used in the different wards. 
The average use in the intensive care units was as high 
as 243 DDD/100 bed-days, while the average use in 
the ward consuming least, neurology, was 15 DDD/ 
100 bed-days. 
As shown in Table 3, the number of bed-days used 
by outpatients increased from 10 921 to 18 618 in the 
study period. The number of discharges and the 
number of inpatient bed-days remained at an almost 
constant level. The proportion of bed-days for out- 
patients increased from 5.3% to 9.0% of the total 
number of bed-days @<0.001). In 1995, the use of 
antibiotics was 37 DDD/100 inpatient bed-days but 34 
DDD/100 total bed-days. 
Blood culture isolates and resistance frequencies 
The number of bacteria isolated from positive blood 
cultures averaged 459 per year (441-475). In total, 1834 
strains were isolated (Table 4). In total 30% of the 
Table 4 
cultures in Roskilde County in the study period 
Distribution of bacterial species isolated from blood 
1992-95 
Species Number of isolates % 
Staphylococcus aureus 
Coagulase-neganve staphylococci 
Streptococcus pneumoniae 
Other streptococci 
Enterococci 
Escherichia coli 
Enterobacter 
Klebsiella 
Salmonella 
Other enterobacteriaceae 
Bacterioider 
Pseudomonas 
Other 
129 
549 
180 
127 
52 
375 
27 
102 
35 
44 
37 
22 
166 
7.0 
9.8 
6.9 
2.8 
1.5 
5.6 
1.9 
2.4 
2.0 
1.2 
9.1 
30 
20 
Total 1834 100 
isolates were coagulase-negative staphylococci, 20% 
Escherichia coli and 9.8% Streptococcus pneumoniae; the 
remaining 40% consisted of other species. In the 
period, the fkaction of Pseudomonas was as low as 1.2% 
and that of Klebsiella was 5.6%. 
The resistance frequencies in the four most 
common species are shown in Table 5. There was no 
significant change in frequency of resistance in any 
species in the study period. 
The total numbers of isolates differ from the 
numbers in Table 4 because not all isolates were tested 
for antibiotic susceptibility. 
Comparison of resistance and the use of antibiotic 
There was no significant change in resistance to any 
relevant antibiotic among any of the blood culture 
isolates, not even when comparing the frequencies of 
resistance in different wards or different ward groups. 
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The resistance in coagulase-negative staphylococci 
to two or more of the three antibiotics tetracycline, 
erythromycin and methicillin was more frequent in the 
intensive care units (32%) than in the other two ward 
groups (12% and 7%) (p<0.05) shown in Table 2. 
DISCUSSION 
The theoretical unit ‘defined daily dose’ makes it 
possible to compare the consumption of antibiotics in 
different regions [23-251. It is important to notice that 
the number of DDDs used does not reveal the number 
of patients treated or the number of treatment courses. 
When comparing the relative use of antibiotics in 
different regions, the denominator plays a major role. 
In primary health care the best denominator would be 
the size of the population, if the use of antibiotics is 
spread equally among all population groups. But this is 
not always the case. In societies with many people 
living in poverty, the selection pressure will be 
underestimated because the use of antibiotics is very 
unevenly distributed in the population. Part of the 
population may not have access to antibiotics for 
economic reasons. Col and O’Connor [23] report very 
low use of antibiotics in countries with major problems 
with resistance. An explanation for this phenomenon 
could be that a large part of the population in these 
developing countries has major difficulties in getting 
access to antibiotics, because of either poverty or lack 
of healthcare facilities. High resistance rates thus relate 
to the small proportion of the population that has 
access to antibiotics, and from which samples for 
microbiological study are obtained. The age distri- 
bution in the population can also play a role, as a greater 
proportion of children and elderly in a population 
results in a higher consumption d e l y  because these 
groups have a higher incidence of infectious diseases. 
When the use of antibiotics in hospital settings is 
compared, the denominator may be of even greater 
importance. The internationally accepted denominator 
is 100 bed-days. In Denmark, the zoncept of ‘bed-day’ 
is defined in guidelines to the counties from the 
National Board of Health, but there is no guarantee 
that the guidelines are interpreted in the same way in 
different counties, or even in diffcrent hospitals in the 
same county. However, as the registration is uniform 
from year to year, minor differences do not disqualify 
the parameter as the best for surveillance. Other 
denominators than the bed-day might be as good, or 
even better, in reflecting the fluctuations in the 
selection pressure in the hospital settings. As can be 
seen in Table 3 the relative reduction in the use of 
antibiotics in Roskilde County From 1992 to 1995 
varies by more than 25% when using different 
denominators. There was a 14% reduction using the 
traditional denominator of 100 bl:d-days. When out- 
patient bed-days were included, the reduction increased 
to 17%. An even larger decrease, 20%, was achieved 
using the number of discharges 1s the denominator. 
The use of antibiotics in the hospital setting is in this 
study presented as DDD/100 bed-days. It should be 
noted that the DDD is defined in adults, and in 
accordance with this fact the pediatric ward is placed 
in ward group 2 instead of ward group 3. 
Table 5 Breakpoints used, number of isolates tested and percentage resistant in the study period 
7 
1992-95 
Breakpoints 
(MIC) Number % resistant 
Species Antibiotics ( m g 4  of isolates str;im 
Streptococcus pneumoniae Penicillin 
Erythromycin 
Staphylococcus aureus Methicillin 
Penicillin 
Erythromycin 
Coagulase-negative staphylococci Methicillin 
Penicillin 
Erythromycin 
Escherichia coli Ampicillin 
Cefuroxime 
Gentamicin 
Trimethoprim 
Fluoroquinolones 
>0.09 
> l  
>1.5 
>0.25 
>1 
>1.5 
>0.25 
>1 
>2  
>4 
>2  
>1.5 
>1 
177 
167 
125 
128 
126 
534 
541 
534 
373 
374 
37 1 
355 
362 
0.6 
1.8 
14 
7:! 
21 
31 
0.5 
0.8 
0.8 
1 t i  
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This study covers all antibiotics sold to inhabitants 
in Roskilde County in the study period. There was a 
2.5% decrease in the total use of antibiotics from 1994 
to 1995. This may reflect a generally increasing aware- 
ness about the importance of following the antibiotic 
policy recommended by the Danish Medical Associ- 
ation. There was an increase of 3.2% in the use of 
cephalosporins in this study but cephalosporins com- 
prised only 0.1% of the total use of antibiotics in the 
primary healthcare sector, almost all being of the 
second-generation type. The increase in the use of 
cephalosporins is therefore of very little importance 
with regard to the development of resistance in isolates 
from the community. In Denmark the use of antibiotics 
in 1995 was 12.7 DDD/1000 inhabitants per day, and 
in Roskilde County it was similar, 13.3 DDD/1000 
inhabitants per day (ATC group J0l alone). A study by 
Sorensen et al. [26] reported that the use of antibiotics 
in Viborg County, Denmark, was 11.3 DDD/1000 
inhabitants per day in primary health care in 1992. 
Baquero et al. [27] reported the use of 19 DDD/1000 
inhabitants per day in 1993 in Spain, 33% higher than 
the use in Denmark. In addition to the higher selection 
pressure, the types of antibiotic are essentially different. 
The use of cephalosporins accounted for 13% of the 
total use in Spain versus 0.9% in Denmark, and the use 
of fluoroquinolones accounted for 6% in Spain in 
contrast to 2.6% in Denmark. In 1985, Eldeen et al. 
(281 reported the use of 19 DDD/1000 inhabitants per 
day in Kuwait and 15 DDD/1000 inhabitants per day 
in Sweden. 
The total increase in the use of antibiotics in 1992 
to 1993 was mainly due to an increase in the use of 
penicillin and 0-lactamase-resistant penicillin. There 
was a large increase in the total use of antibiotics in the 
pediatric ward, from 23 to 31 DDD/100 bed-days. 
This increase was almost solely due to an increase in the 
use of broader-spectrum penicillin, i.e. ampicillin, 
from 10 to 17 DDD/100 bed-days. In the winter of 
1993-94, Roskilde County, like the rest of the country, 
experienced an epidemic of pneumonia caused by 
respiratory syncytial virus (RSV). A large part of the 
increase in the use of ampicillin might be explained by 
the increased use against suspected bacterial pneumonia 
in children with RSV pneumonia. The number of tests 
positive for KSV from the pediatric ward in 1993 was 
20% higher than in 1994 and 1995 (data not shown). 
The epidemic was also reflected by an 8% increase in 
the number of bed-days used. The decrease in the use 
of antibiotics in the pediatric ward from 1994 to 1995 
occurred despite an almost constant number of bed- 
days (14 620 in 1994 and 14 623 in 1995). 
From 1993 to 1995 the total use of antibiotics in the 
Roskilde County hospitals declined by 20%. There were 
no major changes in the activity in the county hospitals 
or any major shifts in the proportion of bed-days used 
by the different wards. As can be seen in Figure 1, the 
largest decreases were seen in the extended-spectrum 
penicillin group from 1993 to 1995 (41%), in the 
cephalosporin group from 1992 to 1993 (37%) arid in 
the penicillin group from 1993 to 1994 (25%). 
The use of antibiotics in the ophthalmologic and 
the otorhinology wards was very variable but because 
they only contribute a minor fraction of the total 
number of bed-days they have a relatively small 
influence on the total use in the ward group. 
Friis et al. [29] reported the use of antibiotics in 
four Danish hospitals in 1984. At that time the use of 
antibiotics was 28-35 DDD/100 bed-days. In the 10- 
year period since 1984 there has been a shift towards 
shorter but more numerous admissions. Consequently, 
the use of antibiotics per admission has remained nearly 
constant: 1.9-2.8 DDD/admission in the four hospitals 
in 1984 as compared to 2.0-2.6 in the study period in 
Roskilde County. There have been some reports of the 
use of antibiotics in hospitals in other countries; 
however, only a few calculated the use in DDD/100 
bed-days. In a study from Bulgaria in 1994 the use was 
around 68 DDD/100 bed-days [30]. 
The most common isolates, as identified in Table 
4, were coagulase-negative staphylococci, accounting 
for 549 of the total of 1834 (30%). The second most 
common species was Escherichia coli accounting for 375 
(20%). Together with Staphylococcus aureus and Strepto- 
coccus pneumoniae, they together accounted for a total of 
67% of the positive blood cultures. This distribution 
was also noted in other Danish materials [31,32]. There 
was a significant increase in the proportion of Staphylo- 
coccus aureus and Streptococcus pneumoniae, as seen in 
other materials [33,34]. The proportion of enterococci 
was reduced to 1.1% of the total number of isolates, a 
reduction also seen in other Danish studies [35]. 
Our resistance frequencies are low compared to the 
frequencies reported from other parts of the world but 
at  the same level as in other Danish counties [32,35]. 
We found less than 1% resistance against penicillin 
and less than 2% resistance against erythromycin in 
pneumococci, as found in Canada [36]. Baquero et al. 
[37] reported resistance levels reaching 40% resistance 
against penicillin, and Pallares et al. [38] 18% resist- 
ance against macrolides in Spain. Methicillin-resistant 
Staphylococcus anreus (MRSA) only accounted for 0.8% 
in Roskilde; in the rest of the world this varied between 
0.8% in Canada [39], 17% in Slovenia [40] and 80% in 
several hospitals in Japan [41]. For Esrkerichia. coli, 
resistance against ampicillin was 31% in Roskilde 
County, the same level as in Canada [36]. In Spain the 
frequency of ampicillin resistance was as high as 
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50-60% [27]. In Spain, 10% of blood isolates of 
Escherichia coli were resistant to fluoroquinolones [27]. 
For comparison, the frequency of resistance to fluoro- 
quinolones was less than 1% in Roskdde County. 
It has been previous shown that coagulase-negative 
staphylococci may be good indicator bacteria for 
surveying bacterial resistance [31]. Many of the 
coagulase-negative staphylococci represent contam- 
ination originating either from the skin of the patient 
or from the skin of the person conducting the blood 
test. Their resistance reflects the use of antibiotics in the 
ward from where they were isolated. The blood tests 
taken on the day of arrival reflect the resistance 
frequencies in the community. It has not been possible 
to evaluate these separately. 
There was no significant correlation between the 
use of antibiotics and antibiotic resistance when testing 
single species against the different groups of antibiotics, 
mainly due to the small number of isolates in ward 
groups 1 and 3. The relationship between the use of 
antibiotics and resistance frequencies may form a 
sigmoid-shaped curve. If this is the case, the fact that 
no correlation was found could be explained by the 
very low use of antibiotics in the county. In Table 2, 
the percentages of coagulase-negative staphylococci 
with resistance to two or three of the antibiotics 
tetracycline, erythromycin and methicillin in each of 
the three ward groups are shown. As can be seen, there 
was a correlation between the level of ‘multiresistance’ 
and the ward groups. 
CONCLUSION 
Even in an area with a very low-consumption of 
antibiotics, it is still possible to reduce the total amount 
used, and to modulate the use of antibiotics towards 
increased use of more narrow spectrum antibiotics, by 
education and guidance-in this case, by active guid- 
ance from the clinical microbiologist and written 
guidelines from the Danish Medical Association. 
Both the use of antibiotics and the frequencies of 
resistance in blood culture isolates are very low in 
Roskilde County as compared to most countries south 
of Denmark. 
In this 4-year study period the changes in the use 
of antibiotics were negligible and were not reflected as 
alterations in the resistance frequencies in single species. 
Even when comparing resistance frequencies in isolates 
from different wards with a different use of antibiotics 
we found no significant differences. 
The resistance of coagulase-negative staphylococci 
to two or more of the three antibiotics tetracycline, 
erythromycin and methicillin was more frequent in the 
intensive care units. 
The need for surveillance of both bacterial resist- 
ance and the use of antibiotics is olmious in a world of 
increasing resistance frequencies. I:? order to compare 
resistance levels in different parts of the world it is of 
great importance to report data in a uniform manner. 
The best is DDD/1000 inhabitants per day in primary 
health care, DDD/100 bed-days in hospitals and resist- 
ance in per cent of a well-defined sample of bacteria. 
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